Aviva plc isn’t the only bargain dividend stock I’d buy today

Aviva plc (LON: AV) could be one of the best dividend stocks out there, and here’s an up-and-coming challenger.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m happy to tell you up front that Aviva (LSE: AV) is one of my favourite FTSE 100 dividend stocks, and that I bought some shares when they were looking a bit battered from the financial crisis fallout.

Aviva’s full-year results had my colleague Rupert Hargreaves asking whether Aviva could be the Footsie buy of the decade, and I share his enthusiasm. Since the resumption of progressive dividends, Aviva has been rapidly ramping up its annual cash payments, while still keeping them adequately covered by growing earnings.

And 2017 was no exception, with the insurance giant upping its dividend by a cracking 18% to 27.4p, for the fourth consecutive year of double-digit growth. The dividend, which yields 5.3% on the current share price, looks to be well supported by earnings, and by cash and liquidity.

Cash

Aviva saw cash remittances rising 33% to £2,398m, with general insurance net written premiums up 11% to £9,141m, and its Solvency II capital surplus improved to £12.2bn. I’m confident that I’m going to carry on receiving my annual dividends.

The firm’s strong cash generation also means it’s paying down debt, is in a strong position to make acquisitions when appropriate, and I think the more focused company presents considerably less risk than it did in the bad days of over-stretching. 

Crucially, I don’t think the reduced risk is yet fully factored into the share price, even bearing in mind that insurance is fundamentally a business built on risk. A forward P/E of only a little over nine, with forecast dividend yields heading above 6%, looks too cheap to me. I think I’ll be using this year’s dividend to buy more shares.

Recovery

I’m alway wary when I see a good dividend payer issue a warning which results in a share price fall, fearing that a cash shortfall and a dividend cut could be just around the corner.

Although a trading update from Emis Group (LSE: EMIS) in January looked solid and it reported a strong balance sheet, a worrying release the same day caused a share price crunch. The company, which specialises in healthcare software and services for GPs, hospitals and pharmacies, told us that its new chief executive had initiated a review of its customer and product support processes. And that it had uncovereda failure to meet certain service levels and reporting obligations with NHS Digital, relating to the Group’s EMIS Web product for GPs in England.

Fundamental failures of that nature can have a long-lasting impact, and a recovery to best practice can take some time. But an examination of Emis’s full-year results on Wednesday is convincing me that this has been a one-off problem and that there’s no real threat to the firm’s dividend.

One-off

Reported operating profit fell 55% to £10.6m, in line with expectations, but adjusted operating profit came in only 3% down at £37.4m. With operating cash generation up 17% to £44.4m, the dividend was lifted by an inflation-busting 10% to yield 3.2%.

Chief executive Andy Thorburn described the service failure as “a serious, but isolated incident.” He went on to assert that Emis continues “to lead the way in joined-up healthcare IT, with market-leading positions, high levels of recurring revenue and a strong financial position.

House broker Numis Securities reckons the Emis share price has fallen too far — which we might expect them to. But I agree.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft owns shares in Aviva. The Motley Fool UK has recommended Emis Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »